Skip to content Skip to footer

Sanders: Democrats’ Drug Pricing Plan “Goes Nowhere Near as Far as It Should”

Sen. Bernie Sanders suggested that pharmaceutical industry lobbying weakened the proposal.

Senate Budget Committee Chairman Bernie Sanders walks out of the U.S. Capitol after delivering a speech against the CHIPS Act on the floor of the Senate on July 25, 2022, in Washington, D.C.

Senate Budget Committee Chair Bernie Sanders on Tuesday blasted Democrats’ watered-down drug pricing plan and suggested pharmaceutical industry lobbying weakened the proposal.

“It’s a very weak proposal. It goes nowhere near as far as it should,” Sanders (I-Vt.) told NBC News’ Sahil Kapur.

The deal unveiled earlier this month would enable Medicare to negotiate the prices of a limited number of prescription drugs. Other provisions include creating a $2,000 out-of-pocket cap for Medicare Part D beneficiaries, stopping brand-name manufacturers from blocking generic options, and penalizing companies that raise prices faster than inflation.

The plan is notably backed by Sen. Joe Manchin (D-W.Va.) — who last year blocked a House-approved budget reconciliation package and said this month that he wouldn’t support new climate spending or tax hikes on the rich and large corporations.

Sanders, who pushed for a sweeping package last year and has long been a leading Medicare for All advocate, pointed to the U.S. Department of Veterans Affairs (VA) as a model for drug price negotiation.

“The American people want Medicare to negotiate prescription drug prices like the VA does,” the senator said Tuesday, according to The Hill.

“The VA has been doing that for decades. The prices they pay are about half as much as Medicare. This thing will only apply to a certain number of drugs,” Sanders continued, noting that parts of the proposal would not take effect until 2026.

“So it’s a weak proposal. Is it better than nothing? I suppose,” he added of Democrats’ plan.

Sanders also took aim at industry lobbying, specifically calling out the trade group Pharmaceutical Research and Manufacturers of America (PhRMA). As he put it: “We’re dealing with the power of PhRMA over the Congress. They don’t lose very often.”

As Common Dreams reported last week, Big Pharma is mobilizing an army of lobbyists to tank Democrats’ drug reform plan while hiking the price of prescription medications.

“Pharma is spending millions to defeat a very modest drug pricing bill,” Sanders tweeted Friday. “Joe Manchin, who is blocking climate action, is the major recipient of fossil fuel campaign contributions. This is how a corrupt political system works.”

We’re not backing down in the face of Trump’s threats.

As Donald Trump is inaugurated a second time, independent media organizations are faced with urgent mandates: Tell the truth more loudly than ever before. Do that work even as our standard modes of distribution (such as social media platforms) are being manipulated and curtailed by forces of fascist repression and ruthless capitalism. Do that work even as journalism and journalists face targeted attacks, including from the government itself. And do that work in community, never forgetting that we’re not shouting into a faceless void – we’re reaching out to real people amid a life-threatening political climate.

Our task is formidable, and it requires us to ground ourselves in our principles, remind ourselves of our utility, dig in and commit.

As a dizzying number of corporate news organizations – either through need or greed – rush to implement new ways to further monetize their content, and others acquiesce to Trump’s wishes, now is a time for movement media-makers to double down on community-first models.

At Truthout, we are reaffirming our commitments on this front: We won’t run ads or have a paywall because we believe that everyone should have access to information, and that access should exist without barriers and free of distractions from craven corporate interests. We recognize the implications for democracy when information-seekers click a link only to find the article trapped behind a paywall or buried on a page with dozens of invasive ads. The laws of capitalism dictate an unending increase in monetization, and much of the media simply follows those laws. Truthout and many of our peers are dedicating ourselves to following other paths – a commitment which feels vital in a moment when corporations are evermore overtly embedded in government.

Over 80 percent of Truthout‘s funding comes from small individual donations from our community of readers, and the remaining 20 percent comes from a handful of social justice-oriented foundations. Over a third of our total budget is supported by recurring monthly donors, many of whom give because they want to help us keep Truthout barrier-free for everyone.

You can help by giving today. Whether you can make a small monthly donation or a larger gift, Truthout only works with your support.